Moderna to Present at Upcoming Conferences in November 2024

CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences:

Guggenheim’s Inaugural Healthcare Innovation Conference, on Tuesday, November 12th at 10:00am ET

UBS Global Healthcare Conference, on Wednesday, November 13th at 3:30pm PT

Jefferies London Healthcare Conference, on Thursday, November 21st at 2:00pm GT

A live webcast of each of these presentations will be available under “Events and Presentations” in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna’s website for at least 30 days following the presentation.

About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on accesswire.com

Staff

Recent Posts

PerfectServe Positioned Furthest for Completeness of Vision in 2024 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

Company views recognition as a reflection of its commitment to advancing clinical communication and productivity…

5 seconds ago

Zero Candida Announces TSX Venture Exchange Listing Date

VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero…

7 seconds ago

Brooks Rehabilitation, Nemours Children’s Health, Wolfson Children’s Hospital and UF Health Jacksonville Partner to Enhance Pediatric Care

JACKSONVILLE, Fla., Nov. 21, 2024 /PRNewswire/ -- By combining resources and expertise, Brooks Rehabilitation, Nemours…

18 seconds ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global…

30 seconds ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate

Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric…

35 seconds ago

Arlington Medical Waste Disposal Company Addresses Rising Needlestick Injuries With Handy Guide

The CDC Reports Approximately 385,000 Needlestick and Sharps-Related Injuries Among U.S. Healthcare Workers AnnuallyARLINGTON, TX…

3 hours ago